Cellebrite DI Ltd (NASDAQ: CLBT) kicked off on Friday, up 1.46% from the previous trading day, before settling in for the closing price of $19.89. Over the past 52 weeks, CLBT has traded in a range of $7.91-$21.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Technology sector has jumped its sales by 18.79% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -218.60%. With a float of $86.02 million, this company’s outstanding shares have now reached $203.23 million.
In an organization with 1008 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 84.45%, operating margin of 14.59%, and the pretax margin is -80.02%.
Cellebrite DI Ltd (CLBT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Software – Infrastructure Industry. The insider ownership of Cellebrite DI Ltd is 58.66%, while institutional ownership is 38.72%. The most recent insider transaction that took place on Nov 29 ’24, was worth 211,161. Before that another transaction happened on Nov 26 ’24, when Company’s Officer proposed sale 67,560 for $19.99, making the entire transaction worth $1,350,524.
Cellebrite DI Ltd (CLBT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -218.60% per share during the next fiscal year.
Cellebrite DI Ltd (NASDAQ: CLBT) Trading Performance Indicators
Take a look at Cellebrite DI Ltd’s (CLBT) current performance indicators. Last quarter, stock had a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.06. Likewise, its price to free cash flow for the trailing twelve months is 41.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.26 in one year’s time.
Technical Analysis of Cellebrite DI Ltd (CLBT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.95 million. That was better than the volume of 1.19 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 86.15%. Additionally, its Average True Range was 0.72.
During the past 100 days, Cellebrite DI Ltd’s (CLBT) raw stochastic average was set at 91.37%, which indicates a significant decrease from 92.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 46.10% in the past 14 days, which was higher than the 38.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $18.17, while its 200-day Moving Average is $13.96. However, in the short run, Cellebrite DI Ltd’s stock first resistance to watch stands at $20.40. Second resistance stands at $20.63. The third major resistance level sits at $20.84. If the price goes on to break the first support level at $19.96, it is likely to go to the next support level at $19.75. The third support level lies at $19.52 if the price breaches the second support level.
Cellebrite DI Ltd (NASDAQ: CLBT) Key Stats
The company with the Market Capitalisation of 4.26 billion has total of 205,932K Shares Outstanding. Its annual sales at the moment are 325,110 K in contrast with the sum of -81,100 K annual income. Company’s last quarter sales were recorded 106,860 K and last quarter income was -207,090 K.
